Lmh Strategic Solutions
$3.1M
Total Income
23
Clients
2
Lobbyists
86
Filings
Income by Year
| Year | Lobbying Income |
|---|---|
| 2024 | $570K |
| 2025 | $2.5M |
Clients
Orchard Therapeutics North AmericaAvadel Pharmaceuticals, PLCPharmaceutical Research and Manufacturers of AmericaMedical Device Manufacturers AssociationGlaxosmithkline LLCIonis Pharmaceuticals, INC.Alkermes, INC.Rare Disease Company CoalitionAlnylam Pharmaceuticals, INC.Erisa Industry Committee (Eric)Stealth Biotherapeutics INC.Neuropace, INC.Ptc Therapeutics, INC.Acadia PharmaceuticalsNeurocrine Biosciences, INC.Regenxbio INC.Travere Therapeutics, INC.Biomarin Pharmaceutical, INC.Ardelyx, INC.Exelixis, INC.Harmony BiosciencesIncyte CorporationSavara INC.
Lobbyists
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.